Emily Lunn
Endocrinology, Diabetes & Metabolism Physician · Greendale, IN
Emily Lunn is an endocrinology, diabetes & metabolism physician with a practice address in Greendale, Indiana, and NPI 1164050779, issued on Mar 30, 2020. Check the license (Indiana 02008663A, as entered in NPPES) on the Medical Licensing Board of Indiana; the Medicare figures below come from public CMS files.
- Name
- Emily Lunn
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License numbers
- 02008663A IN
05511 KY
Self-reported in NPPES; status is on the state search - Practice location
- 1640 Flossie Dr, Greendale, IN 47025
- Phone
- (859) 655-8910
- Enumerated
- Mar 30, 2020
- Record last updated
- Sep 25, 2025
- Fax
- (859) 655-8911
- Medicare enrollment
- Enrolled (PECOS I20251006000489); accepts Medicare assignment
- Medical or professional school
- University Of Pikeville, Kentucky College Of Osteopathic Med, 2020
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 180 in Indiana → Look up another NPI →
Also registered at 1640 Flossie Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Lesley Allen, APRNNurse Practitioner1376793349
- Hannah Briner, CSWSocial Worker1790449577
- Kimberly Cooper, DOPediatrics Physician1386050524
- Katie Davis, APRN, DNPNurse Practitioner1548576531
- Mary Gallaway, MDFamily Medicine Physician1528262516
- Aleah Gibson, M.D.Family Medicine Physician1780792903
Verify Emily Lunn in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Licensing Board of Indiana
Search for license 02008663ACheck the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
82% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
470 Medicare Part D claims for 113 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 57% of claims.
Most prescribed
- Levothyroxine Sodium37 claims
- Ozempic35 claims
- Jardiance22 claims
- Lantus Solostar22 claims
- Mounjaro22 claims
- Trulicity22 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- Summit Medical Group IncGreendale, IN
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Emily Lunn among 180 endocrinology, diabetes & metabolism physician records in Indiana
Emily Lunn is one of 180 endocrinology, diabetes & metabolism physician records with a practice address in Indiana. 79% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2020, is newer than 93% of them.
- NPI issued2020 · 93% of these records are older, 4% newer
- In a Medicare fileYes · 79% of these records are
- In the CMS Doctors and Clinicians fileYes · 65% of these records are
- Graduated2020 · median 2004 among the 117 with a school on file
- Record last updated2025 · 42% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Indiana practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
1 endocrinology, diabetes & metabolism physician record lists a practice address in Greendale
They are 1 of the 67 NPPES records with a practice address in Greendale, and 180 endocrinology, diabetes & metabolism physician records in Indiana.
All 180 in Indiana → Every provider in Greendale → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Ann Collie, DOPeru, IN 469701518096767
- Mateen Hotiana, M.DMarion, IN 469521528267077
- Megan Day, DOKokomo, IN 469021295184323
- Zehra Haider, MDKokomo, IN 469021649270828
- Paula SzczepanczykKokomo, IN 469021487096129
- Vasti Broadstone, MDNew Albany, IN 471501760420137
- Chih Chang, MDSellersburg, IN 471721104835958
- Akhila RamayapallyColumbus, IN 472011356773485
Common questions
What is Emily Lunn's NPI number?
Emily Lunn's National Provider Identifier (NPI) is 1164050779, issued on Mar 30, 2020. An NPI identifies a provider in billing; it is not a license.
Where is Emily Lunn located?
The NPPES record lists a practice address at 1640 Flossie Dr, Greendale, IN, 47025. Phone: (859) 655-8910. Providers update this record themselves, so call before visiting.
How can I verify Emily Lunn's license?
NPPES lists Indiana license number 02008663A, as entered by the provider. Search the Medical Licensing Board of Indiana at https://www.in.gov/pla/professions/physicians-home/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Emily Lunn prescribe under Medicare Part D?
In 2024, Emily Lunn had 470 Medicare Part D claims for 113 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.